Delivery Order SPE2DB20D9214-SPE2DB25FD4YC
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency for Stelara 90 mg/mL syringes valued at $16,249.95. The award was issued on June 24, 2025, with an ultimate completion date of July 16, 2025, under a firm fixed-price delivery order contract with no set-aside designation. This delivery order represents a single procurement action under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on June 2, 2025, with an ultimate completion date of June 24, 2025, was awarded without a set-aside designation. The award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. The contract, awarded on July 23, 2025, carries an ultimate completion date of August 13, 2025, and represents a direct delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $32,499.90 for Stelara 90 mg/mL syringes under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The award, issued on August 29, 2025, with an ultimate completion date of September 22, 2025, represents a specific product delivery against the company's larger Indefinite Delivery Contract (IDC) with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $40,179.29 by the Defense Logistics Agency on September 15, 2025. This delivery order, with an ultimate completion date of October 6, 2025, covers the supply of Stelara 90 mg/mL syringes to support Department of Defense healthcare operations. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency valued at $16,249.95 for Stelara 90 mg/ml syringes. The award, issued on July 14, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of August 4, 2025. This delivery order was issued without a set-aside designation, leveraging the company's competitive standing as a woman-owned...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 on August 19, 2025, for the supply of Stelara 90 mg/ml syringes. The delivery order, which carries a firm fixed price and is not subject to any set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain division and must be completed by September 10, 2025. This award represents a single delivery order...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency on September 12, 2025. This delivery order, without set-aside designation, calls for the supply of Stelara 90 mg/ml syringes to support Department of Defense healthcare requirements. The award is expected to be completed by October 3, 2025, with performance taking place at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency's Medical Supply Chain on August 1, 2025. The delivery order is for Stelara 90 mg/ml syringes, with an ultimate completion date of August 22, 2025. This award carries no set-aside designation, allowing the vendor to compete on its merits within the broader federal procurement...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency on September 9, 2025. The award is for the supply of Stelara 90 mg/mL syringes, a biologic medication used to treat autoimmune conditions. This firm fixed-price delivery order is scheduled for completion by September 30, 2025, with no set-aside designation applied. The contract leverages DMS...
- SPE2DB20D9214Indefinite Delivery Contract
- SPE2DB20D9214-SPE2DB25FD4YCDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order from the Defense Logistics Agency valued at $16,249.95 for Stelara 90 mg/ml syringes. Awarded on September 17, 2025, with an ultimate completion date of October 8, 2025, this firm fixed-price delivery order carries no set-aside designation. The contract represents a direct procurement under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency, valued at approximately $500 million and valid through November 2026, which authorizes the issuance of delivery orders for pharmaceutical products supporting military healthcare facilities nationwide. This delivery order exemplifies the Defense Logistics Agency's ongoing pharmaceutical supply chain management, whereby it issues targeted firm fixed-price orders for specific medications to support Department of Defense medical operations. Stelara, a biologic immunosuppressant medication, would be distributed through DMS Pharmaceutical Group's established supply chain to military health facilities. The company's federal contract portfolio demonstrates consistent success in competing for pharmaceutical procurement opportunities with the Defense Logistics Agency, leveraging its woman-owned small business status and specialized expertise in distributing branded and generic prescription drugs, biologics, and medical consumables to government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 9/17/25 |